Related Experiment Videos
From animal experiments to clinical dosing: some aspects of preclinical development of antidepressants
1Research and Development, Ciba-Geigy Ltd., Basel, Switzerland.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Assessment of sexual dysfunction in depressed patients and reporting attitudes in routine daily practice: Results of the postmarketing observational studies with moclobemide, a reversible MAO-A inhibitor.
International journal of psychiatry in clinical practice·2014
Benzodiazepines and GABA hypothesis of schizophrenia.
Journal of psychopharmacology (Oxford, England)·2012
Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers.
Journal of psychopharmacology (Oxford, England)·2011
Delayed onset of action of antidepressant drugs? Survey of recent results.
European psychiatry : the journal of the Association of European Psychiatrists·2009
Onset of action under antidepressant treatment.
European psychiatry : the journal of the Association of European Psychiatrists·2009
Onset of improvement under fluoxetine and moclobemide.
European psychiatry : the journal of the Association of European Psychiatrists·2009
Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group.
Psychopharmacology series·1993
Open or closed? Structural characterization of plasma-derived and recombinant human plasminogen across multiple resolution scales.
International journal of biological macromolecules·2026
Emergency Department-Administered Extended-Release Buprenorphine After Fentanyl Overdose Reversed by Emergency Medical Services With Naloxone.
The Journal of emergency medicine·2026
[Advances in the application of Janus kinase inhibitors for the uncommon pediatric dermatological disorders].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.
Expert opinion on pharmacotherapy·2026